Whole Exome Sequencing in Familial Parkinson Disease

Request Access

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

W. Nichols, N. Pankratz, D. Hernandez, et al.. (2005). The Lancet. Cited 473 times. https://doi.org/10.1016/S0140-6736(05)17828-3

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

N. Pankratz, J. Wilk, J. Latourelle, et al.. (2009). Human Genetics. Cited 468 times. https://doi.org/10.1007/s00439-008-0582-9

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

N. Pankratz, W. Nichols, Sean K. Uniacke, et al.. (2002). American journal of human genetics. Cited 192 times. https://doi.org/10.1086/341282

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families.

N. Pankratz, W. Nichols, Sean K. Uniacke, et al.. (2003). Human molecular genetics. Cited 149 times. https://doi.org/10.1093/HMG/DDG270

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations

Nathan Pankratz, Diane Kissell, M. Pauciulo, et al.. (2009). Neurology. Cited 85 times. https://doi.org/10.1212/WNL.0b013e3181af7a33
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747